219 related articles for article (PubMed ID: 34875000)
41. A computational approach to drug repurposing using graph neural networks.
Doshi S; Chepuri SP
Comput Biol Med; 2022 Nov; 150():105992. PubMed ID: 36228466
[TBL] [Abstract][Full Text] [Related]
42. MDIPA: a microRNA-drug interaction prediction approach based on non-negative matrix factorization.
Jamali AA; Kusalik A; Wu FX
Bioinformatics; 2020 Dec; 36(20):5061-5067. PubMed ID: 33212495
[TBL] [Abstract][Full Text] [Related]
43. NMF-mGPU: non-negative matrix factorization on multi-GPU systems.
Mejía-Roa E; Tabas-Madrid D; Setoain J; García C; Tirado F; Pascual-Montano A
BMC Bioinformatics; 2015 Feb; 16():43. PubMed ID: 25887585
[TBL] [Abstract][Full Text] [Related]
44. A network integration approach for drug-target interaction prediction and computational drug repositioning from heterogeneous information.
Luo Y; Zhao X; Zhou J; Yang J; Zhang Y; Kuang W; Peng J; Chen L; Zeng J
Nat Commun; 2017 Sep; 8(1):573. PubMed ID: 28924171
[TBL] [Abstract][Full Text] [Related]
45. DeepDRK: a deep learning framework for drug repurposing through kernel-based multi-omics integration.
Wang Y; Yang Y; Chen S; Wang J
Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33822890
[TBL] [Abstract][Full Text] [Related]
46. Drug repositioning using drug-disease vectors based on an integrated network.
Lee T; Yoon Y
BMC Bioinformatics; 2018 Nov; 19(1):446. PubMed ID: 30463505
[TBL] [Abstract][Full Text] [Related]
47. Computational Methods for Drug Repurposing.
Rapicavoli RV; Alaimo S; Ferro A; Pulvirenti A
Adv Exp Med Biol; 2022; 1361():119-141. PubMed ID: 35230686
[TBL] [Abstract][Full Text] [Related]
48. Computational Drug Repositioning with Random Walk on a Heterogeneous Network.
Luo H; Wang J; Li M; Luo J; Ni P; Zhao K; Wu FX; Pan Y
IEEE/ACM Trans Comput Biol Bioinform; 2019; 16(6):1890-1900. PubMed ID: 29994051
[TBL] [Abstract][Full Text] [Related]
49. NerLTR-DTA: drug-target binding affinity prediction based on neighbor relationship and learning to rank.
Ru X; Ye X; Sakurai T; Zou Q
Bioinformatics; 2022 Mar; 38(7):1964-1971. PubMed ID: 35134828
[TBL] [Abstract][Full Text] [Related]
50. Drug Repurposing for Newly Emerged Diseases via Network-based Inference on a Gene-disease-drug Network.
Qin L; Wang J; Wu Z; Li W; Liu G; Tang Y
Mol Inform; 2022 Sep; 41(9):e2200001. PubMed ID: 35338586
[TBL] [Abstract][Full Text] [Related]
51. MOKPE: drug-target interaction prediction via manifold optimization based kernel preserving embedding.
Binatlı OC; Gönen M
BMC Bioinformatics; 2023 Jul; 24(1):276. PubMed ID: 37407927
[TBL] [Abstract][Full Text] [Related]
52. Gene prioritization using Bayesian matrix factorization with genomic and phenotypic side information.
Zakeri P; Simm J; Arany A; ElShal S; Moreau Y
Bioinformatics; 2018 Jul; 34(13):i447-i456. PubMed ID: 29949967
[TBL] [Abstract][Full Text] [Related]
53. NTD-DR: Nonnegative tensor decomposition for drug repositioning.
Jamali AA; Tan Y; Kusalik A; Wu FX
PLoS One; 2022; 17(7):e0270852. PubMed ID: 35862409
[TBL] [Abstract][Full Text] [Related]
54. Computationally repurposing drugs for breast cancer subtypes using a network-based approach.
Firoozbakht F; Rezaeian I; Rueda L; Ngom A
BMC Bioinformatics; 2022 Apr; 23(1):143. PubMed ID: 35443626
[TBL] [Abstract][Full Text] [Related]
55. Network-Based Drug Repositioning: Approaches, Resources, and Research Directions.
Alaimo S; Pulvirenti A
Methods Mol Biol; 2019; 1903():97-113. PubMed ID: 30547438
[TBL] [Abstract][Full Text] [Related]
56. Overlap matrix completion for predicting drug-associated indications.
Yang M; Luo H; Li Y; Wu FX; Wang J
PLoS Comput Biol; 2019 Dec; 15(12):e1007541. PubMed ID: 31869322
[TBL] [Abstract][Full Text] [Related]
57. MDTips: a multimodal-data-based drug-target interaction prediction system fusing knowledge, gene expression profile, and structural data.
Xia X; Zhu C; Zhong F; Liu L
Bioinformatics; 2023 Jul; 39(7):. PubMed ID: 37379157
[TBL] [Abstract][Full Text] [Related]
58. gene2drug: a computational tool for pathway-based rational drug repositioning.
Napolitano F; Carrella D; Mandriani B; Pisonero-Vaquero S; Sirci F; Medina DL; Brunetti-Pierri N; di Bernardo D
Bioinformatics; 2018 May; 34(9):1498-1505. PubMed ID: 29236977
[TBL] [Abstract][Full Text] [Related]
59. Predicting and understanding comprehensive drug-drug interactions via semi-nonnegative matrix factorization.
Yu H; Mao KT; Shi JY; Huang H; Chen Z; Dong K; Yiu SM
BMC Syst Biol; 2018 Apr; 12(Suppl 1):14. PubMed ID: 29671393
[TBL] [Abstract][Full Text] [Related]
60. DRviaSPCN: a software package for drug repurposing in cancer via a subpathway crosstalk network.
Wu J; Li X; Wang Q; Han J
Bioinformatics; 2022 Oct; 38(21):4975-4977. PubMed ID: 36066432
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
